| Name: | Aripiprazole EP Impurity F |
| Catalogue No. | VL197008 |
| CAS No. | 573691-09-5 |
| Molecular Formula | C23H27Cl2N3O3 |
| Molecular Weight | 464.38 |
| Status | In-stock |
| IUPAC Name | 4-(2,3-Dichlorophenyl)-1-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl) piperazine 1-oxide |
| Synonyms | Aripiprazole Related Compound F /Aripiprazole N-Oxide |
| Appearance | White powder |
| Description | Aripiprazole EP Impurity F (Aripiprazole N1-Oxide) is formed by degradation of Aripiprazole. Aripiprazole is a novel antipsychotic with partial agonist activity at dopamine D2 receptors, bound with high affinity to recombinant human 5-HT1A receptors is an efficacious treatment for the positive and negative symptoms of schizophrenia. |
| References | Jordan, Shaun, et al. “The Antipsychotic Aripiprazole Is a Potent, Partial Agonist at the Human 5-HT1A Receptor.” European Journal of Pharmacology, vol. 441, no. 3, Apr. 2002, pp. 137–40, https://doi.org/10.1016/s0014-2999(02)01532-7. |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)
